William F Doyle

Director; Director, Executive Chairman · 2 filings · Latest: May 28, 2026

NovoCure Ltd

PROKIDNEY CORP.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
NVCR	William F Doyle	Director, Executive Chairman	Mar 3, 2026	Sale	$12.98	71,887	$932.9K	328,397	Mar 5 9:30 PM
NVCR	WILLIAM DOYLE	—	Mar 3, 2026	Proposed Sale	$12.98	71,887	$932.9K	—	Mar 3 10:01 PM